Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Endocrinology | Family Medicine
Disease Category: High Cholesterol (Hyperlipidemia)
Location: United States, CT
Are you 65 or over with high cholesterol?
Researchers want to find out if a drug called ezetimibe (Zetia)
can help people with high cholesterol who are at high risk for
heart disease. The purpose of this study is to give ezetimibe to
some people to see if it is safe and can help them when taken with
another drug called atorvastatin (Lipitor). The study doctor is
also doing this study to see if taking ezetimibe and atorvastatin
together is better than taking atorvastatin alone.
Both ezetimibe and atorvastatin are approved by the FDA for us
in people with high cholesterol. Giving people ezetimibe and
atorvastatin together for high cholesterol is an approved and
acceptable use of both drugs; however, for purposes of this study,
giving these drugs together will be considered an investigational
use of the drugs. The word "investigational" means this
use is still being tested and is not approved by the FDA for people
who are at high risk for heart disease.
As part of this study you will be asked the
Patient Inclusion Criteria
Patient Exclusion Criteria
For more information,
CW ID: 109267
Date Last Changed:
July 25, 2013
Tom Grotta, PresidentStamford Therapeutics Consortium47 Oak StreetStamford, CT 06905Phone: 203-325-8529Fax: 203-325-0069
Research Center Information: Stamford Therapeutics Consortium
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.